Wellington Management Group LLP Sells 1,615,529 Shares of IQVIA Holdings Inc. (NYSE:IQV)

Wellington Management Group LLP reduced its holdings in IQVIA Holdings Inc. (NYSE:IQV) by 99.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 8,685 shares of the medical research company’s stock after selling 1,615,529 shares during the quarter. Wellington Management Group LLP’s holdings in IQVIA were worth $2,058,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of the business. First Foundation Advisors raised its holdings in IQVIA by 3.8% during the 2nd quarter. First Foundation Advisors now owns 1,161 shares of the medical research company’s stock worth $245,000 after purchasing an additional 43 shares during the last quarter. Invera Wealth Advisors LLC increased its position in shares of IQVIA by 0.3% during the second quarter. Invera Wealth Advisors LLC now owns 14,506 shares of the medical research company’s stock worth $3,183,000 after buying an additional 46 shares during the period. Private Trust Co. NA raised its stake in IQVIA by 10.7% during the third quarter. Private Trust Co. NA now owns 485 shares of the medical research company’s stock worth $115,000 after buying an additional 47 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in IQVIA by 0.3% during the second quarter. Oregon Public Employees Retirement Fund now owns 15,668 shares of the medical research company’s stock valued at $3,313,000 after acquiring an additional 48 shares during the last quarter. Finally, Clear Harbor Asset Management LLC grew its holdings in IQVIA by 1.3% during the 3rd quarter. Clear Harbor Asset Management LLC now owns 3,969 shares of the medical research company’s stock worth $941,000 after acquiring an additional 50 shares during the period. Institutional investors own 89.62% of the company’s stock.

IQVIA Trading Down 2.9 %

Shares of IQV stock opened at $190.97 on Thursday. IQVIA Holdings Inc. has a 52-week low of $187.62 and a 52-week high of $261.73. The company has a 50-day simple moving average of $210.32 and a two-hundred day simple moving average of $223.64. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The company has a market capitalization of $34.66 billion, a price-to-earnings ratio of 25.06, a PEG ratio of 2.05 and a beta of 1.49.

Analysts Set New Price Targets

Several brokerages recently commented on IQV. The Goldman Sachs Group cut their target price on IQVIA from $280.00 to $250.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. Truist Financial reduced their price objective on shares of IQVIA from $265.00 to $261.00 and set a “buy” rating for the company in a research report on Thursday, December 12th. TD Cowen cut their target price on shares of IQVIA from $270.00 to $255.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. JPMorgan Chase & Co. decreased their price target on shares of IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a research note on Tuesday, November 5th. Finally, Barclays cut their price objective on shares of IQVIA from $260.00 to $255.00 and set an “overweight” rating on the stock in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $256.19.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.